Spolytech Past Earnings Performance
Past criteria checks 0/6
Spolytech's earnings have been declining at an average annual rate of -59.5%, while the Chemicals industry saw earnings growing at 9.2% annually. Revenues have been declining at an average rate of 15.7% per year.
Key information
-59.5%
Earnings growth rate
-59.4%
EPS growth rate
Chemicals Industry Growth | 13.9% |
Revenue growth rate | -15.7% |
Return on equity | -4.1% |
Net Margin | -3.4% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Key Things To Consider Before Buying Spolytech Co., Ltd. (KOSDAQ:050760) For Its Dividend
May 05Spolytech (KOSDAQ:050760) Seems To Use Debt Quite Sensibly
Mar 23Spolytech Co., Ltd.'s (KOSDAQ:050760) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Mar 02Why Spolytech Co., Ltd. (KOSDAQ:050760) Should Be In Your Dividend Portfolio
Feb 04Did You Participate In Any Of Spolytech's (KOSDAQ:050760) Fantastic 298% Return ?
Jan 14Spolytech Co., Ltd. (KOSDAQ:050760) Passed Our Checks, And It's About To Pay A ₩50.00 Dividend
Dec 24Is Spolytech (KOSDAQ:050760) Using Too Much Debt?
Dec 23Is Weakness In Spolytech Co., Ltd. (KOSDAQ:050760) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Dec 02Revenue & Expenses Breakdown
How Spolytech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 75,412 | -2,588 | 10,414 | 806 |
31 Mar 24 | 73,842 | -4,222 | 10,424 | 801 |
31 Dec 23 | 73,218 | -5,476 | 10,864 | 861 |
30 Sep 23 | 72,264 | -7,376 | 11,159 | 844 |
30 Jun 23 | 72,794 | -5,886 | 11,252 | 799 |
31 Mar 23 | 74,018 | -3,824 | 11,286 | 842 |
31 Dec 22 | 82,460 | -2,828 | 11,331 | 813 |
30 Sep 22 | 89,491 | 4,202 | 11,673 | 830 |
30 Jun 22 | 97,833 | 4,147 | 11,929 | 819 |
31 Mar 22 | 105,871 | 3,299 | 11,913 | 747 |
31 Dec 21 | 109,764 | 5,327 | 11,278 | 734 |
30 Sep 21 | 113,912 | 3,127 | 11,538 | 710 |
30 Jun 21 | 128,233 | 4,912 | 13,588 | 775 |
31 Mar 21 | 137,248 | 7,289 | 15,355 | 957 |
31 Dec 20 | 135,243 | 7,724 | 15,512 | 1,093 |
30 Sep 20 | 135,562 | 11,748 | 15,155 | 1,144 |
30 Jun 20 | 129,279 | 11,648 | 13,059 | 1,084 |
31 Mar 20 | 127,953 | 11,745 | 11,173 | 889 |
31 Dec 19 | 135,033 | 10,743 | 10,956 | 705 |
30 Sep 19 | 143,374 | 12,298 | 10,594 | 620 |
30 Jun 19 | 142,495 | 8,340 | 10,496 | 665 |
31 Mar 19 | 141,727 | 4,381 | 11,019 | 761 |
31 Dec 18 | 136,887 | 1,513 | 11,317 | 833 |
30 Sep 18 | 128,803 | -4,025 | 11,332 | 778 |
30 Jun 18 | 126,352 | -3,712 | 11,799 | 770 |
31 Mar 18 | 121,770 | -2,983 | 11,826 | 752 |
31 Dec 17 | 122,283 | -3,056 | 11,959 | 789 |
30 Sep 17 | 124,168 | 1,646 | 12,396 | 924 |
30 Jun 17 | 124,817 | 2,799 | 12,140 | 972 |
31 Mar 17 | 123,491 | 3,518 | 11,623 | 924 |
31 Dec 16 | 117,697 | 3,938 | 11,296 | 915 |
30 Sep 16 | 111,269 | 1,796 | 10,877 | 864 |
30 Jun 16 | 106,250 | 1,044 | 11,102 | 767 |
31 Mar 16 | 101,808 | -145 | 11,760 | 839 |
31 Dec 15 | 100,317 | -1,715 | 12,062 | 951 |
30 Sep 15 | 102,326 | -4,611 | 13,080 | 985 |
30 Jun 15 | 101,550 | -5,127 | 12,627 | 1,099 |
31 Mar 15 | 106,765 | -5,645 | 12,227 | 1,021 |
31 Dec 14 | 112,566 | -4,350 | 12,116 | 865 |
30 Sep 14 | 116,168 | -1,468 | 11,257 | 790 |
30 Jun 14 | 121,455 | -570 | 10,948 | 737 |
31 Mar 14 | 122,709 | 856 | 10,955 | 796 |
31 Dec 13 | 118,349 | 1,415 | 10,805 | 952 |
30 Sep 13 | 116,916 | 62 | 13,259 | 1,161 |
Quality Earnings: A050760 is currently unprofitable.
Growing Profit Margin: A050760 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A050760 is unprofitable, and losses have increased over the past 5 years at a rate of 59.5% per year.
Accelerating Growth: Unable to compare A050760's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A050760 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-7.3%).
Return on Equity
High ROE: A050760 has a negative Return on Equity (-4.12%), as it is currently unprofitable.